Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

IMMEDIATE CARE OF OKLAHOMA, LLC

NPI: 1780239202 · OKLAHOMA CITY, OK 73099 · Urgent Care Clinic/Center · NPI assigned 08/02/2019

$518K
Total Medicaid Paid
7,283
Total Claims
7,183
Beneficiaries
16
Codes Billed
2020-06
First Month
2024-11
Last Month

Provider Details

Authorized OfficialPENWELL, KEVIN (PRESIDENT/COM)
NPI Enumeration Date08/02/2019

Related Entities

Other providers sharing the same authorized official: PENWELL, KEVIN

ProviderCityStateTotal Paid
IMMEDIATE CARE OF OKLAHOMA LLC OKLAHOMA CITY OK $1.42M
IMMEDIATE CARE OF OKLAHOMA, LLC TECUMSEH OK $1.20M
IMMEDIATE CARE OF OKLAHOMA L.L.C. OKLAHOMA CITY OK $762K
IMMEDIATE CARE OF OKLAHOMA LLC NORMAN OK $642K
IMMEDIATE CARE OF OKLAHOMA LLC NORMAN OK $380K
IMMEDIATE CARE OF OKLAHOMA LLC EDMOND OK $230K

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2020 685 $56K
2021 2,123 $152K
2022 2,297 $174K
2023 1,596 $101K
2024 582 $35K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99204 Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity 1,033 1,033 $150K
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 1,234 1,205 $136K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc 1,265 1,229 $64K
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 781 771 $61K
99203 Office or other outpatient visit for the evaluation and management of a new patient, low complexity 494 494 $47K
87428 709 703 $21K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe 260 258 $8K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 535 531 $8K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 122 120 $6K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 198 194 $6K
87430 254 251 $4K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) 80 78 $3K
99051 185 183 $1K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets 13 13 $1K
87400 82 82 $1K
87807 38 38 $442.70